About Us

Jean-Olivier Marty

President

Artak Harutunyan

Co-President

Scott Jamieson

Vice President

Grant Tarsi

Vice President

Michael Allen Company has once again successfully received a SOC 2 Type II attestation report. This report reflects our ongoing commitment to maintaining high standards in our organization’s information systems and processes.

Since initiating our first SOC audit in 2017, we have consistently committed to high standards and controls. Every year, we undergo an independent audit to assure our clients that their data is secure, and our systems are resilient.

We look forward to continuing to deliver our research and consulting insights with the trust, security, and reliability our clients expect.

Jean-Olivier Marty

President

  • 22 years of Biopharma experience
  • Wide therapeutic area expertise including Immunology, Cardiovascular, Metabolic & Oncology
  • Areas of focus:
    • SAPPHIRE™ brand health tracker
    • Market structure / market mapping
    • Segmentation
    • Patient flow modeling / forecasting
    • Positioning, branding and communication

Artak Harutunyan

Co-President

  • 24 years of Biopharma experience
  • Wide therapeutic area expertise, including Oncology and Rare Diseases
  • Areas of focus:
    • Market structure / market mapping
    • Segmentation / positioning / messaging
    • Patient flow modeling / forecasting
    • Demand / conjoint studies
    • SAPPHIRE™ brand health tracker

Scott Jamieson

Vice President

  • 34 years of management consulting experience, with 25 years in biopharma and medical products
  • Strategic and market planning, research and commercial operations expertise

Grant Tarsi

Vice President

  • 14 years biopharma experience
  • Broad therapeutic area knowledge
  • Areas of focus:
    • Real-world data analytics (claims, EHR)
    • Market sizing
    • Market structure / market mapping
    • Patient journey / flow modeling
    • Forecasting
    • Demand studies